PITUITARY ENLARGEMENT

This adverse event was reported 204 times

These drugs are most commonly taken by patients reporting PITUITARY ENLARGEMENT:

# Drug Count
0 IPILIMUMAB 37
1 NIVOLUMAB 21
2 OCTREOTIDE ACETATE 19
3 PEGVISOMANT 9
4 CABERGOLINE 8
5 METFORMIN 8
6 METFORMIN ER 500 MG 8
7 METFORMIN ER 750 MG 8
8 PREDNISONE 8
9 INTERFERON BETA-1A 7
See all common drugs associated with PITUITARY ENLARGEMENT

PITUITARY ENLARGEMENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGVISOMANT 9 0.0022
1 CABERGOLINE 8 0.0016
2 ESTRADIOL VALERATE 1 0.0013
3 LAZERTINIB 1 0.0012
4 IPILIMUMAB 37 0.0008
5 SENNA LAXATIVE 1 0.0008
6 LIDOCAINE AND PRILOCAINE 1 0.0007
7 CEFACLOR 1 0.0006
8 OCTREOTIDE ACETATE 19 0.0006
9 BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES 1 0.0006
See all drugs enriched for association with PITUITARY ENLARGEMENT